Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionVirginia Retirement Systems Et Al
Latest Disclosed Ownership14,600 shares
Latest Disclosed Value $ 557,866
Virginia Retirement Systems Et Al ownership in TVTX / Travere Therapeutics, Inc.

On February 4, 2026 - Virginia Retirement Systems Et Al filed a 13F-HR form disclosing ownership of 14,600 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $557,866 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 22, 2019 disclosing 0 shares of Travere Therapeutics, Inc.. The current value of the position is $659,920 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-04 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 14,600 14,600 558 0.0033
2019-10-22 2019-09-30 13F RETROPHIN COM 761299106 0 -23,100 -100.00 0 -100.00
2019-07-26 2019-06-30 13F RETROPHIN COM 761299106 23,100 2,600 12.68 464 0.00 0.0053
2019-04-25 2019-03-31 13F RETROPHIN COM 761299106 20,500 1,800 9.63 464 9.69 0.0055
2019-02-07 2018-12-31 13F RETROPHIN COM 761299106 18,700 300 1.63 423 -20.04 0.0057
2018-11-02 2018-09-30 13F RETROPHIN COM 761299106 18,400 -11,200 -37.84 529 -34.45 0.0061
2018-08-03 2018-06-30 13F RETROPHIN COM 761299106 29,600 -30,700 -50.91 807 -40.13 0.0099
2018-05-04 2018-03-31 13F RETROPHIN COM 761299106 60,300 3,900 6.91 1,348 13.47 0.0163
2018-02-02 2017-12-31 13F RETROPHIN COM 761299106 56,400 -31,600 -35.91 1,188 -45.75 0.0140
2017-11-09 2017-09-30 13F RETROPHIN COM 761299106 88,000 14,700 20.05 2,190 54.12 0.0267
2017-08-07 2017-06-30 13F RETROPHIN COM 761299106 73,300 -1,800 -2.40 1,421 2.53 0.0178
2017-05-08 2017-03-31 13F RETROPHIN COM 761299106 75,100 37,400 99.20 1,386 94.12 0.0179
2017-02-02 2016-12-31 13F RETROPHIN COM 761299106 37,700 -1,900 -4.80 714 -19.41 0.0099
2016-10-31 2016-09-30 13F RETROPHIN COM 761299106 39,600 1,400 3.66 886 30.29 0.0128
2016-08-10 2016-06-30 13F RETROPHIN COM 761299106 38,200 23,800 165.28 680 144.60 0.0100
2016-01-21 2015-12-31 13F RETROPHIN COM 761299106 14,400 400 2.86 278 -1.77 0.0042
2015-10-27 2015-09-30 13F RETROPHIN COM 761299106 14,000 14,000 283 0.0043
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.